Announcements
Projects
Orgs
Project Post
Articles 872
Votes 0
Barron's

Authors 74

Bill Alpert
Connor Smith
Jacob Sonenshine
Jack Denton
Logan Moore
Joe Woelfel
Eric J. Savitz
Andrew Bary
Sabrina Escobar
Al Root
Josh Nathan-Kazis
Teresa Rivas
Angela Palumbo
Debbie Carlson
Reshma Kapadia
Nicholas Jasinski
Tae Kim
Elizabeth O'Brien
Ben Levisohn
Lawrence C. Strauss
Lisa Beilfuss
Joe Light
Carleton English
Kenneth Corbin
Neal Templin
Adam Clark
Ed Lin
Lauren R. Rublin
Janet H. Cho
Karishma Vanjani
Jacob Adelman
Andrew Welsch
Jack Hough
Megan Cassella
Lauren Foster
Brian Swint
Shaina Mishkin
Emily Dattilo
Avi Salzman
Michael Kops
Randall W. Forsyth
Fang Block
Callum Keown
Louis Rosenberg
Abby Schultz
Evie Liu
Karen Petrou
Leslie Lipschitz
Thomas Hoenig
Maria Moats
Paul Washington
Nathan Sheets
Rupert Steiner
Megan Leonhardt
Liz Moyer
Julie Gralow
Matt Bemer
Christopher Smart
Lisa Scherzer
Paulo Trevisani
Dow Jones Newswires
Philip Waller
Dan Molinski
Dominic Chopping
Sarah Needleman
Michael W. Peregrine
Craig Mellow
Barron's
Nate Wolf
Elsa Ohlen
Giulia Petroni
Miriam Mukuru
Renae Dyer
Emese Bartha
Pioneer Natural, Exxon, MGM, Walmart, Aehr Test Systems, Levi Strauss, and More Market Movers - Barron's
almost2y
Restaurant and Hotel Hiring Drove the Jobs Surge. What's Behind the Numbers? - Barron's
almost2y
GM Stock Falls After Report of Potential Airbag Recall - Barron's
almost2y
The Case for Buying Big Tech Stocks Now - Barron's
almost2y
Costco Wholesale's September Sales Were Strong, Company Says. Gas Prices Helped. - Barron's
almost2y
VinFast Stock's Swings Are Crazy. Average Move Is 22%. - Barron's
almost2y
Meta Unveils New AI Tools for Advertisers - Barron's
almost2y
Apple Stock Is Falling After a Downgrade. Four Reasons for Caution. - Barron's
almost2y
Kevin McCarthy Is Out After Averting Government Shutdown. The U.S. Got Something Worse. - Barron's
almost2y
It’s Time to 'Buy a T Bill and Chill,' Says DoubleLine’s Gundlach - Barron's
almost2y
HP Inc., WK Kellogg, McCormick, Point Biopharma, Oddity, and More Stock Market Movers - Barron's
almost2y
Lilly to Buy Point Biopharma. Cancer-Treatment Stock Surges 84%. - Barron's
almost2y
Tesla Stock Has Defied Bad News. Wall Street Thinks That Can Last Forever. - Barron's
almost2y
McCormick Stock Falls as Sales Hit by China's Slow Economic Recovery - Barron's
almost2y
HP Inc., WK Kellogg, Point Biopharma, Warby Parker, McCormick, and More Market Movers - Barron's
almost2y
Tesla Relaunches Rear-Wheel-Drive Model Y in U.S. at Lower Price. Stock Falls. - Barron's
almost2y
Boeing Stock Was Awful in September. The Case for Staying Invested. - Barron's
almost2y
BYD Tops Tesla, Takes Global EV Production Crown - Barron's
almost2y
Rivian Gets an Upgrade, Reports Strong Deliveries. The Stock Is Down. - Barron's
almost2y
Discover Is the Best Performer in the S&P 500 Monday. Why the Stock Is Up. - Barron's
almost2y
Tesla, NIO, Rivian, AMC, Apple, and More Stock Market Movers - Barron's
almost2y
Sam Bankman-Fried's Trial Is a Reminder for Crypto Traders to Be Wary - Barron's
almost2y
Levi's, Conagra, McCormick, and More Stocks to Watch This Week - Barron's
almost2y
Why Now Is the Time to Buy Stocks - Barron's
almost2y
High Blood Pressure and Seniors: Why Doctors Might Not Treat It - Barron's
almost2y